Clinical Trial Update: Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of albuterol sulfate for intermittent or persistent mild asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol sulfate (Albuterol sulfate)

Snippet

Sponsor: Acerus Pharmaceuticals Corporation | Conditions: Asthma | Phase 2 | Status: WITHDRAWN